Role of JAK/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial–mesenchymal transition

W Jin - Cells, 2020 - mdpi.com
The JAK/STAT3 signaling pathway plays an essential role in various types of cancers.
Activation of this pathway leads to increased tumorigenic and metastatic ability, the transition …

Mir-34: a new weapon against cancer?

G Misso, MT Di Martino, G De Rosa, AA Farooqi… - … therapy-nucleic acids, 2014 - cell.com
The microRNA (miRNA)-34a is a key regulator of tumor suppression. It controls the
expression of a plethora of target proteins involved in cell cycle, differentiation and …

Targeting the JAK/STAT signaling pathway using phytocompounds for cancer prevention and therapy

S Bose, S Banerjee, A Mondal, U Chakraborty… - Cells, 2020 - mdpi.com
Cancer is a prevalent cause of mortality around the world. Aberrated activation of Janus
kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway …

Regulation and function of autophagy in pancreatic cancer

J Li, X Chen, R Kang, H Zeh, DJ Klionsky, D Tang - Autophagy, 2021 - Taylor & Francis
Oncogenic KRAS mutation-driven pancreatic ductal adenocarcinoma is currently the fourth-
leading cause of cancer-related deaths in the United States. Macroautophagy (hereafter …

Therapeutic potential of PPARγ natural agonists in liver diseases

L Wu, C Guo, J Wu - Journal of cellular and molecular …, 2020 - Wiley Online Library
Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR
family. The biological functions are complex and diverse. PPARγ plays a significant role in …

Cancer stem cells and the tumor microenvironment: targeting the critical crosstalk through nanocarrier systems

A Nayak, NM Warrier, P Kumar - Stem cell reviews and reports, 2022 - Springer
The physiological state of the tumor microenvironment (TME) plays a central role in cancer
development due to multiple universal features that transcend heterogeneity and niche …

MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib

P Stiuso, N Potenza, A Lombardi, I Ferrandino… - … Therapy-Nucleic Acids, 2015 - cell.com
Hepatocellular carcinoma (HCC) is the third cause of cancer-related deaths worldwide.
Sorafenib is the only approved drug for patients with advanced HCC but has shown limited …

Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells

J Chun, RJ Li, MS Cheng, YS Kim - Cancer letters, 2015 - Elsevier
The important goal of cancer drug discovery is to develop therapeutic agents that are
effective, safe, and affordable. In the present study, we demonstrated that alantolactone …

[HTML][HTML] Recent studies of 5-fluorouracil resistance in pancreatic cancer

WB Wang, Y Yang, YP Zhao, TP Zhang… - World journal of …, 2014 - ncbi.nlm.nih.gov
Abstract Resistance to 5-fluorouracil (5-FU), an important anticancer drug, is a serious
challenge in the treatment of pancreatic cancer. Equilibrative nucleoside transporter 1 and …

PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy

GI Manfredi, A Dicitore, G Gaudenzi, M Caraglia… - Endocrine, 2015 - Springer
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) pathway is a central hub for the regulation of cell proliferation, apoptosis, cell cycle …